Its overexpression is associated with chemoresistance, whereas CIP2A silencing sensitizes NSCLC cells to cisplatin, suppresses proliferation and colony formation, and promotes apoptosis, accompanied by reduced Akt activation [25]. Here, AKT1 is linked to non-small cell lung carcinoma.